Back

Elevated lipoprotein(a) is highly prevalent in ischaemic heart failure with reduced ejection fraction and shows sex-related differences

9 May 2026 (09:38 - 10:47)
Organised by: Logo
Congress Presentation Part of: ePosters in coronary artery disease (chronic) / chronic coronary syndromes (1) Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kaloyan Dyankov

University Hospital Alexandrovska, Sofia (Bulgaria)

6 More presentations in this session

Presentation thumbnail
Effect of intravenous iron on quality of life in older adults with acute coronary syndrome: a phase IV clinical study
Doctor C. Bonanad Lozano (Valencia, ES)
Abstract Slides
Presentation thumbnail
Clinical profile and outcomes of young patients with ST-elevation myocardial infarction
Ms A. Costa (Penafiel, PT)
Abstract Slides
Presentation thumbnail
Cardiac rehabilitation: a key determinant of post-myocardial infarction outcomes
Doctor M. Moura (Porto, PT)
Abstract Slides
Presentation thumbnail
Inclisiran in addition to statin therapy lowers lipoprotein(a) and improves one-year outcomes in young patients with familial hypercholesterolemia and coronary artery disease
Doctor K. Dyankov (Sofia, BG)
Abstract Slides
Presentation thumbnail
Emergency coronary artery bypass surgery after PCI at hospitals with versus without on-site surgical backup: a systematic review and meta-analysis
Doctor M. Soomro (Karachi, PK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in coronary artery disease (chronic) / chronic coronary syndromes (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 09:38 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources